Matinas BioPharma | 8-K: Current report
Apr 5 07:03 ET
Matinas BioPharma | 424B5: Prospectus
Apr 4 16:18 ET
Matinas BioPharma | 8-K: Current report
Mar 28 09:04 ET
Matinas BioPharma | 8-K: Current report
Mar 27 16:29 ET
Matinas BioPharma | 10-K: Annual report
Mar 27 16:06 ET
Matinas BioPharma | 8-K: Current report
Mar 25 08:08 ET
Matinas BioPharma | 8-K: Current report
Mar 22 09:22 ET
Matinas BioPharma | 8-K: Current report
Mar 22 06:36 ET
Matinas BioPharma | 8-K: Current report
Feb 26 08:10 ET
Matinas BioPharma | 8-K: Current report
Feb 20 07:38 ET
Matinas BioPharma | 8-K: Current report
Jan 9 00:00 ET
Matinas BioPharma | 8-K: Current report
Dec 27, 2023 00:00 ET
Matinas BioPharma | 8-K: Current report
Dec 21, 2023 07:40 ET
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Matkovits Theresa
Dec 15, 2023 21:46 ET
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Hoover Thomas
Dec 15, 2023 21:46 ET
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Kucinski Keith A
Dec 15, 2023 21:46 ET
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Chief Technology Officer Liu Hui
Dec 15, 2023 21:46 ET
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Jabbour Jerome D
Dec 15, 2023 21:46 ET
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Ferguson James J. III
Dec 15, 2023 21:46 ET
Matinas BioPharma | 8-K: Current report
Nov 20, 2023 07:30 ET
No Data
No Data